MIP podcasts
MIP podcasts
Jun 24, 2020
MIP's Charlotte Kilpatrick talks to Corey Salsberg of Novartis, Ellen t’Hoen of Medicines Law and Policy, and David Rosenberg formerly of GSK to discuss how COVID-19 is reshaping IP in the life sciences.
Play • 48 min

Charlotte Kilpatrick, reporter at Managing IP, sat down with Corey Salsberg of Novartis, Ellen t’Hoen of Medicines Law and Policy, and David Rosenberg formerly of GSK, to discuss how COVID-19 is reshaping the IP landscape in the life sciences industries. The guests debated IP issues including access to medicine, open science, and the role patent and technology pooling can play to accelerate vaccine research.

More episodes
Search
Clear search
Close search
Google apps
Main menu